Tech Transfer
Technology transfer at the NYGC involves dedicated personnel who identify research results with potential commercial interest, such as patentable inventions, tangible materials, and/or copyrighted materials. Strategies are then enacted to facilitate their transfer to for-profit entities for further development that may lead to commercialization.
Pathways to Market
The process varies and may involve licensing agreements, joint ventures, or other alliances to share the benefits and risks of introducing new technologies to market. Additionally, alternative approaches like spin-outs might be utilized when the NYGC lacks the requisite resources, interest, and/or expertise to develop a new technology.
Technologies Available for Licensing
- Droplet Microfluidic Washing For High-Throughput Bioassays
- Recombinant CRISPR-Cas9 Nucleases with Altered PAM Specificity
- High-Throughput RNA-Targeting Pooled CRISPR Screens and CRISPR-Cas13 Guide Design
- Scalable Pooled CRISPR Screens with Single Cell Chromatin Accessibility Profiling
- Chemically Modified Cas13 Guides Enhance CRISPR-Cas13 RNA-Targeting Effects
Contact Us
